Wednesday - September 23, 2026
Herbert Smith Freehills Kramer Advises Telix Pharmaceuticals Limited on Its Transformational Merger With ITM Isotope Technologies Munich SE
September 23, 2026
NEW YORK, Sept. 23 -- Herbert Smith Freehills Kramer LLP, a law firm, issued the following news:

* * *

Herbert Smith Freehills Kramer advises Telix Pharmaceuticals Limited on its transformational merger with ITM Isotope Technologies Munich SE

22 Sep 2026

Herbert Smith Freehills Kramer (HSF Kramer) is pleased to have advised Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) (Telix) on its transformational merger with ITM Isotope Technologie . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products